Utrecht, 14 April 2022 – The National Growth Fund invests 325 million euros in the Oncode-PACT plan to accelerate the preclinical
A game-changer in small molecule lead discovery. Pivot Park Screening Centre (PPSC) is the first contract research organization (CRO) that
Oss, the Netherlands and Mannheim, Germany – 21 February 2022 PPSC and CeMOS have formed a strategic partnership to provide
Pivot Park Screening Centre is one of the creators of the ‘Preclinical Drug Discovery’ Radboud Summer School hosted by Pivot
Oxford Global Discovery UK brings the most innovative event that aims to provide an open and stimulating scientific and cultural exchange.
In this webinar we provide an overwiew of application demands for a reliable sample preparation automation and highlight the challenges that need to be overcome to improve lab processes